MRI activity appeared to be a more sensitive measure of disease activity in secondary progressive multiple sclerosis (SPMS) than relapses, an analysis of two datasets showed. "When we interrogated a ...
MRI results may not be effective at indicating disability for patients with secondary progressive multiple sclerosis (SPMS), new research suggests. Analysis from the phase 3 ASCEND trial of almost 900 ...
The International Progressive MS Alliance announces the launch of its MS Clinical and Imaging Data Resource (CIDR), which provides the academic and research community access to anonymized and ...
MONTREAL, Dec. 20, 2018 /PRNewswire/ -- NeuroRx Research () announced today the online release of an Original Research Article published in Multiple Sclerosis Journal and describing a novel method ...
A retrospective, five-year study of 1,314 patients with multiple sclerosis (MS) has found that atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which ...
New evidence added to the literature that paramagnetic rim lesions (PRLs) may be a biomarker of disability accumulation in multiple sclerosis (MS). PRLs are thought to capture a subset of chronic ...
A UB research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from ...
You havent had a relapse of multiple sclerosis (MS) symptoms in years, and your last few MRI scans have come back stable. So why is it getting harder to walk around the block or up a flight of stairs?
Patrick Vermersch, MD, PhD, University of Lille, France discusses the next steps in frexalimab trials and the findings that have surprised him the most thus far, the second part of an interview. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results